China Economic Herald and China Development Network News reporter Qiu Aiquan reported in Shanghai June 27-28, initiated by the Shanghai Association for Science and Technology, and hosted by the Shanghai Baoshan District People’s Government and the Shanghai Society of Genetics, the "2021 Shanghai Science and Technology Forum-Shanghai Genetics The “Molecular Diagnosis Industry-University-Research Conference” was held in Gaojing Town, Baoshan. Experts and scholars at the conference exchanged views on the interpretation of laws, regulations and policies, the transformation of innovative technologies, and the development of the molecular diagnosis industry after the epidemic, in order to gain insights into the latest research progress, bloom academic ideas, and promote The molecular diagnostic technology of genomics detection explores the challenges faced by the intellectual property strategy and legal standardization in response to the rapid development of scientific and technological innovation.

The theme of this conference is "Promoting scientific and technological innovation and entrepreneurship, and empowering the development of precision medicine." At the opening ceremony, academicians Jin Li and Su Guohui of the Chinese Academy of Sciences brought highly professional academic reports, while Professor Yang Zhenglin and Professor Yang Xiaohong respectively Starting from their respective fields, bring analysis reports based on clinical research data, telling the layout and prospects of future scientific and technological development.

In addition, "Intellectual Property Strategy for Technological Innovation", "Biomedicine IPO Regulation Guarantee", "Emerging Molecular Diagnostic Technology Upgrading Industry Pattern", "Looking for a Partner-IVD Entrepreneurship, Waiting for Your C-Debut", "Multidimensional Precision Breast Cancer Treatment" Seven sub-forums including "New Technology Sub-forums", "New Trends in Tumor Diagnosis and Treatment", and "The Road to Transformation from Scientific Research to Clinical Metabolomics" were launched one after another, from the legal, academic, industrial, and venture capital communities. Big coffee, experts and scholars, leading corporate figures, and senior investors, the stars gather together, the stars shine, it can be called an academic feast.

Tumor and breast cancer have always been a health issue of public concern, as well as a treatment problem that has been difficult to overcome in clinical practice. Traditional technologies have encountered bottlenecks and emerging technologies have gradually risen. Molecular diagnostic technology and mass spectrometry technology have become the “new favorites” in the industry. High hopes are placed on them. Based on the principle of academic research, the ultimate goal is to serve the clinic and benefit human health. Starting from a large dimension, the topics of this sub-forum include many medical subdivisions and explore in combination with practical applications; there are also discussions on intellectual property laws and regulations and IPO listing strategies in the field of biomedical health, starting from a coping perspective, and bringing targeted professions answer.

In recent years, Baoshan District has made every effort to promote the construction of the main position of the Shanghai Science and Technology Innovation Center, accelerate the new pace of "Northern Transformation", and build an integrated development pattern of "South Headquarters + North Manufacturing". The North Shanghai Biomedicine Industrial Park, one of the city's five characteristic biomedical parks in the north, has both industrial space and location advantages. Shangyao Kangsino, a manufacturer of a shot of the new crown vaccine, has a vaccine production base here. There is also the Xinyangwan Biomedical Industrial Park in Gaojing Town in the south. Since the opening of the park in 2019, a number of high-quality companies such as Sinopharm Medical Devices, Sinopharm Medical Engineering, Runda Rongjia, and Di'an Diagnostics have gathered. Headquarters type biomedical park. Baoshan District has planned its layout ahead of time and has successively introduced numerous biomedical companies with explosive power in the biomedical subdivision track, and promoted the construction of upstream and downstream ecological chains. The benefits of regional clusters have become increasingly obvious, and continued to inject strong momentum into technological innovation and entrepreneurship.

The relevant person in charge of Baoshan District said: In February last year, Baoshan District took the lead in Shanghai in introducing 38 measures to support the development of the biomedical industry in 7 areas. This year, it has successively launched a series of hard-core supporting policies such as the 10 key enterprise-benefit measures for optimizing the business environment, the "30 scientific and technological innovations" for promoting high-quality economic development, and the "Golden Ten" policies on the ring road. Biopharmaceutical companies settled and developed in Baoshan will enjoy the best policy support, best corporate services, and best business environment.